HSBC Holdings
TLSI icon

HSBC Holdings’s TriSalus Life Sciences TLSI Stock Holding History

HSBC Holdings’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-730,322
Closed -$7.25M – 3194
2022
Q3 		$7.25M Hold
730,322
– – 0.01% 1029
2022
Q2 		$7.19M Buy
730,322
+430,324
+143% +$4.23M 0.01% 1044
2022
Q1 		$2.94M Hold
299,998
– – ﹤0.01% 1419
2021
Q4 		$2.98M Sell
299,998
-234,053
-44% -$2.33M ﹤0.01% 1499
2021
Q3 		$5.28M Buy
534,051
+234,053
+78% +$2.29M 0.01% 1128
2021
Q2 		$2.94M Hold
299,998
– – ﹤0.01% 1295
2021
Q1 		$2.89M Buy
+299,998
New +$3.04M ﹤0.01% 1194

Other funds holding TLSI

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DFCM
Dark Forest Capital Management San Juan, Puerto Rico $1.13B AUM 18.74% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HSBC Holdings's TLSI Position: Q4 2022 in Review

HSBC Holdings sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 730,322 shares — an estimated $7.25M sold.

HSBC Holdings first reported a position in TLSI in Q1 2021 and held it in 7 quarters. The position peaked at $7.25M in Q3 2022. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

  • HSBC Holdings reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
  • HSBC Holdings sold 730,322 TriSalus Life Sciences shares in Q4 2022, an estimated $7.25M.
  • HSBC Holdings first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 7 quarters.
  • HSBC Holdings's TriSalus Life Sciences position peaked at $7.25M in Q3 2022.
  • 9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on HSBC Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.